ArticleCJC open2022

Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study.

Milan Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.